Clinical Trial Update: DMB-I in the Treatment of Alzheimer Type Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial of DMB-I for Alzheimer's disease–related dementia has completed; the update notes the study status but does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• DMB-I (DMB-I)

Snippet

Sponsor: Bigespas LTD | Conditions: Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 | Status: COMPLETED